Santen Pharmaceutical Enterprise Account Executive Salaries in Albuquerque, NM
The average Santen Pharmaceutical Enterprise Account Executive in Albuquerque, NM earns an estimated $84,855 annually, which includes an estimated base salary of $74,352 with a $10,503 bonus. Santen Pharmaceutical's Enterprise Account Executive compensation is $28,619 less than the US average for a Enterprise Account Executive. Enterprise Account Executive salaries at Santen Pharmaceutical in Albuquerque, NM can range from $35,500 - $175,000.
In Albuquerque, NM, The Business Development Department at Santen Pharmaceutical earns $2,575 more on average than the Operations Department.
Last updated 4 years ago.
- $74,352
- avg. base
- $10,503
- avg. bonus
Enterprise Account Executive Salaries at Santen Pharmaceutical
In Albuquerque, NM, Enterprise Account Executives earn $2,568 more than Account Executives, and $13,073 less than Account Managers.
Compensation at Santen Pharmaceutical by Department
In Albuquerque, NM, The Business Development Department averages $2,575 more than the Operations Department, and $814 less than the IT Department
Enterprise Account Executive Compensation by Gender (All Companies)
The average female Enterprise Account Executive at companies similar size to Santen Pharmaceutical reported making $102,476, while the average male Enterprise Account Executive at similar sized companies reported making $112,728.
Enterprise Account Executive Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Enterprise Account Executive at companies similar size to Santen Pharmaceutical reported making $141,122, while the average African American/Black Enterprise Account Executive at similar sized companies reported making $73,075.
How Enterprise Account Executives at Santen Pharmaceutical Rate Their Compensation
The majority of Enterprise Account Executives at Santen Pharmaceutical believe they're not compensated fairly. 50% of Enterprise Account Executives at Santen Pharmaceutical say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Santen Pharmaceutical
